GUARDD Study
Anthropometry (7)
- 12M_BMI - Body Mass Index calculated based on baseline height and 12 Month visit weight. (phv00389186.v1.p1)
- 12M_WEIGHT - Subject's weight upon enrollment 12 Month visit (phv00389187.v1.p1)
- 3M_BMI - Body Mass Index calculated based on baseline height and 3 Month visit weight. (phv00389182.v1.p1)
- 3M_WEIGHT - Subject's weight upon 3 Month visit (phv00389183.v1.p1)
- BL_BMI - Body Mass Index calculated based on weight and height at baseline enrollment visit. (phv00389177.v1.p1)
- BL_HEIGHT - Height measured at enrollment baseline visit (phv00389178.v1.p1)
- BL_WEIGHT - Subject's weight upon enrollment baseline visit (phv00389179.v1.p1)
Biomarkers (6)
- 12M_DIASTOLIC_BLOOD_PRESSURE - Average Diastolic blood pressure at the time of 12 Month visit (phv00389189.v1.p1)
- 12M_SYSTOLIC_BLOOD_PRESSURE - Average Systolic blood pressure at the time of 12 Month visit (phv00389188.v1.p1)
- 3M_DIASTOLIC_BLOOD_PRESSURE - Average Diastolic blood pressure at the time of 3 Month visit (phv00389185.v1.p1)
- 3M_SYSTOLIC_BLOOD_PRESSURE - Average Systolic blood pressure at the time of 3 Month visit (phv00389184.v1.p1)
- BL_DIASTOLIC_BLOOD_PRESSURE - Average diastolic blood pressure at the time of baseline enrollment visit (phv00389181.v1.p1)
- BL_SYSTOLIC_BLOOD_PRESSURE - Average systolic blood pressure at the time of baseline enrollment visit (phv00389180.v1.p1)
Demographics (2)
- AGE - Age at the time of data import from data warehouse or enrollment (phv00389176.v1.p1)
- SEX - Sex of participant (phv00389174.v1.p1)
Medications (1)
- BP_MEDICATION - Self reported use of blood pressure medication at baseline visit (phv00389190.v1.p1)
Race and Ethnicity (1)
- RACE - All patients self identified as having Black or African ancestry (phv00389175.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte type of the sample (phv00389198.v1.p1)
- APOL1_STATUS - Apol1 Risk status based on genetic test result in layman's terms (phv00389193.v1.p1)
- BODY_SITE - Area the sample was collected from (phv00389197.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00389168.v1.p1)
- EDUCATION - Completed level of education as of baseline visit (phv00389191.v1.p1)
- GENOTYPE - Apol1 genotype result (phv00389194.v1.p1)
- HISTOLOGICAL_TYPE - Type of sample collected (phv00389195.v1.p1)
- IS_TUMOR - Tumor status of the sample (phv00389199.v1.p1)
- RANDOMIZATION_ASSIGNMENT - Whether patient was randomly assigned to genetic testing on their baseline visit, or delayed (control) genetic testing at their 12 month visit. (phv00389173.v1.p1)
- SAMPLE_COLLECTION_METHOD - How sample for genetic testing was collected (phv00389196.v1.p1)
- SAMPLE_ID - De-Identified Sample ID (phv00389192.v1.p1)
- SAMPLE_ID - De-identified subject sample ID (phv00389170.v1.p1)
- SAMPLE_USE - Sample Use (phv00389171.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00389172.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00389169.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00389167.v1.p1)